PATENT CLAIM ANALYSIS

Application Number: 16077575
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-02
Patent Classification: ["514", "252120"]

Abstract:
The present invention provides for compositions and methods for the treatment of Parkinson's disease comprising a compound of formula (i): or a pharmaceutically effective salt or ester thereof alone or in combination with L-DOPA to provide a synergistic effect, thereby providing methods of (1) treating patients with Parkinson's Disease for whom L-DOPA is no longer effective, (2) treating patients with Parkinson's Disease who developed dyskinesia due to L-DOPA, (3) treating patients with Parkinson's Disease who have are receiving deep brain stimulation and (4) treating patients with Parkinson's Disease whose symptoms interfere with activities of daily living.

Claim (Index 12):
The method of  claim 10 , wherein the compound of formula (i) is administered in a dose ranging from about 1 to about 100 mg/kg/day.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 96.0
- Lexical Diversity: 1.70588
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14170791', '15755435', '11470012', '14113340', '15634262']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082759569663905
- 35 USC 102 Novelty (BERT): 0.5504143798098774
- Combined Prediction Score: 0.7824897992507392
- Mean Citation Score: 381.899742
- Max Citation Score: 411.88565
- Similarity Product: 320.21577071577906

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test